Caffeine + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Energy Expenditure
Conditions
Energy Expenditure
Trial Timeline
Oct 2, 2007 → Apr 21, 2008
NCT ID
NCT00781586About Caffeine + Placebo
Caffeine + Placebo is a approved stage product being developed by Bayer for Energy Expenditure. The current trial status is completed. This product is registered under clinical trial identifier NCT00781586. Target conditions include Energy Expenditure.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00781586 | Approved | Completed |
Competing Products
1 competing product in Energy Expenditure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| r-metHuLeptin | Amgen | Phase 1 | 32 |